Discovery of new biomarkers/validation/technologies

Among hundreds of thousands of cancer biomarkers have been discovered, only few of them have been approved during the past two decades by the FDA for monitoring response, surveillance, or recurrence of cancer. To be a clinically applicable and reliable biomarker, it must be of value for informing clinical decision-making to improve the patient outcome. Initially, CB have to distinguish between people with cancer and those without. In fact, many biomarkers do not achieve beyond this point because the investigators are either unable to develop robust, accurate assay methods, or this biomarker lacks sufficient sensitivity and/or specificity. Actually, there was very low rate (0.1%) of successful clinical translation of biomarker. Developing new cancer biomarkers has been formulated in stepwise manner. About 15 years ago, Hammond and Taube proposed an approach for CB development starting from discovering the marker, developing an assay method for assessment, analyzing its clinical potential preliminarily, standardization of its assay, and finally validation of such biomarker for clinical use.

    Related Conference of Discovery of new biomarkers/validation/technologies

    June 27-28, 2023

    13th Annual Summit on Advanced Bionics

    Vienna, Austria
    June 28-29, 2023

    27th Global Congress on Biotechnology

    Paris, France
    July 10-11, 2023

    3rd World Congress on Food Science and Biotechnology

    Prague, Czech Republic
    September 25-26, 2023

    6th Annual Congress on Biosimilars

    Taipei, Taiwan
    October 23-24, 2023

    3rd International Conference on Bioprinting

    Los Angeles, USA
    October 23-24, 2023

    8th International summit on Biomanufacturing

    Los Angeles, USA
    October 23-24, 2023

    27th European Biotechnology Congress

    Rome, Italy
    November 21-22, 2023

    27th Biotechnology Congress: Research & Innovations

    Berlin, Germany

    Discovery of new biomarkers/validation/technologies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in